95 results
Page 4 of 5
6-K
EX-99.1
fad 6cthvzt0ktf
21 Apr 21
Current report (foreign)
6:30am
UPLOAD
s7gptsrfi 58ev75
19 Jan 21
Letter from SEC
12:00am
F-3
abadzrevhcsq
13 Jan 21
Shelf registration (foreign)
1:59pm
F-3
EX-3.1
sytdclzif
13 Jan 21
Shelf registration (foreign)
1:59pm
6-K
EX-99.1
bbnc2btqeyxkj5k0756h
5 Jan 21
Innate’s First NK Cell Engager Selected by Sanofi as Drug Candidate for Development
6:30am
6-K
EX-99.2
smulg6l3mpci2 q8
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
6-K
EX-99.1
4ziw4xd
16 Jul 20
Innate Pharma Announces the Appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer
6:30am
20-F
EX-12.1
oy3xfv 6f4bjw6
24 Apr 20
Annual report (foreign)
10:43am
20-F
EX-12.2
i7y0e dphea
24 Apr 20
Annual report (foreign)
10:43am
20-F
s01an1
24 Apr 20
Annual report (foreign)
10:43am
20-F
EX-1.1
6tjni 5nl66gtp
24 Apr 20
Annual report (foreign)
10:43am
424B4
0asmh57c9n
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-6/A
EX-99
ty3o953
9 Oct 19
Registration for ADRs (foreign) (amended)
5:05pm
F-1/A
r42eth fz2s
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1/A
EX-4.1
uemsk9dl e3ny8v43
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-6
EX-99
yjkrxx a5v59fratz2i
3 Oct 19
Registration for ADRs (foreign)
10:26am
F-1
EX-3.1
iyjak
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.3
i3fl1hv p0kvgn3
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.4
eff6u3ne
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.2
0t3boubh4o0wro93ohc
20 Sep 19
Registration statement (foreign)
4:08pm